Search the Newsreel

Price to sales forward of MaxCyte, Inc. – MUN:MYE0

This page from TradingView provides financial information for MaxCyte, Inc. (MUN:MYE0), specifically focusing on its forward price-to-sales ratio. The article indicates that market data is provided by ICE Data Services and reference data by FactSet, with SEC filings from Quartr.

MaxCyte Q2 Results: EPS beats estimates, revenue falls 14.5% YoY

MaxCyte Inc. reported Q2 2026 results, with EPS beating estimates at $(0.08) despite a 14.53% year-over-year revenue decrease to $7.271 million. The company narrowed its net loss by 33.33% and announced a new strategic partnership with Genentech. MaxCyte also reaffirmed its full-year 2026 revenue …

MaxCyte Inc (MXCT) (Q2 2026) Earnings Call Highlights: Strategic Pivot to Enterprise ...

MaxCyte Inc. reported a 15% decrease in total revenue for Q2 2026, reaching $7.3 million, with core revenue down 21%. Despite this, the company exceeded expectations and highlighted significant growth in CASGEVY royalties and a new enterprise-level partnership with Genentech to diversify revenue streams. …

Is Maximus Stock Worth Buying as Low Valuation Meets Contract Risk?

Maximus (MMS) stock trades at a deep earnings discount, but this reflects near-term uncertainty due to federal procurement delays and contract sensitivity. While the company has a strong sales pipeline and improved liquidity, its current Zacks Rank #5 (Strong Sell) and unfavorable earnings estimate …

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against CarMax, Inc. (KMX) and Encourages Investors to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC has launched an investigation into potential corporate wrongdoing at CarMax, Inc. (NYSE: KMX). The firm is encouraging investors who purchased CarMax securities prior to June 20, 2025, and continue to hold them, to come forward and assist with the …

IMAX (IMAX) Stock Looks Fully Valued Despite Cash Flow Upside

Revenue Beat: Lumax Industries Limited Beat Analyst Estimates By 6.3%

Max Stock (TASE:MAXO) Stock Commands A Premium After Margin Surge

MaxCyte narrows Q2 2026 loss 28%, signs Genentech deal

MaxCyte (NASDAQ:MXCT) Issues Earnings Results

MaxCyte (NASDAQ:MXCT) reported a slight beat on earnings with an adjusted loss of $0.08 per share against an expected $0.09 loss, and revenue of $6.5 million, largely meeting estimates. The company reaffirmed its 2026 revenue guidance of $30 million–$32 million, anticipating instrument placements to …

MediaAlpha director Eugene Nonko sells $454,595 in company stock

MediaAlpha director Eugene Nonko sold $454,595 worth of Class A Common Stock between August 10 and August 12, 2026, through a Rule 10b5-1 trading plan. These sales were primarily to cover taxes from vesting restricted stock units. The company recently reported record Q2 revenue …

MediaAlpha (MAX) director Nonko sells 34,461 shares in planned trades

MediaAlpha, Inc. director Eugene Nonko sold a total of 34,461 shares of Class A common stock between August 10 and August 12, 2026, through multiple open-market transactions. These sales, conducted under a Rule 10b5-1 trading plan, included both directly held shares and those held …

MaxLinear Inc (MXL) Stock Up 7.7% but GF Value Says Overvalued -- GF Score: 57/100

MaxLinear Inc (MXL) shares rose 7.7% to $74.33, but GuruFocus's GF Value indicates the stock is significantly overvalued by 273.3%, with an intrinsic value of $19.91. The company's GF Score of 57/100 reflects average performance with strong financial strength but poor valuation and profitability. …

XMax Inc. Finalizes Aerora Share Acquisition and Private Fund Investment on August 10, 2026

XMax Inc. has announced the completion of two significant transactions on August 10, 2026. The company acquired 561,426 ordinary shares of Aerora Technology Co., Ltd. for approximately US$12 million and finalized a private investment fund subscription of $8.4 million through its indirect subsidiary, Preamble …

Earnings call transcript: MaxCyte tops Q2 2026 revenue forecast, shares fall

MaxCyte reported Q2 2026 revenue of $7.3 million, exceeding analyst expectations, though shares fell after hours due to a year-over-year sales decline and lower margins. The company highlighted stabilization in the cell therapy market and a new enterprise partnership with Genentech as key developments. …

$MXCT ($MXCT) Releases Q2 2026 Earnings

MaxCyte Reports Second Quarter 2026 Financial Results

MaxCyte, Inc. announced its financial results for the second quarter ended June 30, 2026, reporting total revenue of $7.3 million, a 15% decrease year-over-year, and a net loss of $8.9 million, an improvement from the $12.4 million loss in Q2 2025. The company reiterated …

Himax Technologies (HIMX) Posts Stronger Q2 And Guidance, Is The Valuation Still Cheap?

Himax Technologies (HIMX) recently reported strong Q2 2026 results with increased revenue and net income, alongside positive Q3 guidance. Despite a 106.41% one-year total shareholder return, the stock has seen a 27.23% pullback in 90 days. While a popular narrative suggests a fair value …

MaxCyte, Inc. (MXCT) Reports Q2 Loss, Beats Revenue Estimates

MaxCyte, Inc. (MXCT) reported a Q2 loss of $0.08 per share, exceeding the Zacks Consensus Estimate of a $0.12 loss, and surpassed revenue estimates with $7.27 million. Despite beating earnings and revenue expectations in some recent quarters, the stock has underperformed the market this …

MaxLinear (NASDAQ:MXL) Shares Up 8.2% - Should You Buy?

MaxLinear (NASDAQ:MXL) shares rose 8.2% to $74.71 in mid-day trading on Wednesday, despite trading volume being 85% below its average daily level. The company recently exceeded quarterly expectations, reporting $0.35 EPS against $0.33 expected and $168.85 million in revenue against a $164.64 million forecast, …

CarMax Named to PEOPLE’s 2026 Companies That Care List for Seventh Time

CarMax, Inc. has been recognized for the seventh time on PEOPLE magazine's 2026 Companies That Care list, ranking #70, in partnership with Great Place To Work®. This award highlights CarMax's strong people-first culture and its commitment to community engagement, with 100% of its locations …

CarMax Named one of the 2026 PEOPLE® Companies That Care

RICHMOND, VA, Aug. 12, 2026 (GLOBE NEWSWIRE) -- CarMax, Inc. (NYSE: KMX) has been named as one of the 2026 PEOPLE® Companies That Care, ranking #70 and marking the company's seventh appearance on the list. This recognition, presented by PEOPLE magazine and Great Place …

Can Maximus Weather the VA Contract Hit and Rebuild Earnings Momentum?

Maximus, Inc. (MMS) faces a near-term earnings setback due to a temporary pause in performance incentives for a major Department of Veterans Affairs contract, which significantly contributed to profitability. This has led to a reduction in fiscal 2026 adjusted earnings and free cash flow …

CARMAX, INC. (NYSE: KMX) SHAREHOLDER INVESTIGATION ALERT:

Bernstein Liebhard LLP is investigating potential breaches of fiduciary duty by directors and officers of CarMax, Inc. (NYSE: KMX). The law firm encourages current CarMax shareholders who purchased shares before June 20, 2025, to contact them to learn about their legal rights. The investigation …

MoneyMax Financial Services (SGX:5WJ) Stock Rebounds While Debt Questions Persist

Singapore's Heptamax International preliminary half-year revenue surges

AQR Capital Management (KMX) discloses 4.67% beneficial ownership in CarMax

AQR Capital Management and its parent company, AQR Capital Management Holdings, LLC, have disclosed a 4.67% beneficial ownership stake in CarMax Inc. (KMX) through an amended Schedule 13G filing. This amounts to 6,622,794 shares, with both entities reporting shared voting power over 6,492,745 shares …

Himax Technologies (HIMX) details 2026 AGM resolutions in Form 6-K filing

Himax Technologies (HIMX) filed a Form 6-K detailing the resolutions from its annual general meeting of members held on August 12, 2026, in Tainan, Taiwan. Key resolutions included the adoption of the company's 2025 audited financial statements and the re-election of Mr. Liang-Gee Chen …

Max Healthcare Institute Shares Fall 2.17%; Stock Among Nifty 50 Losers

Shanghai Chicmax Cosmetic to Buy 29% Stake in Shanghai Yiye for 384M Yuan

Transcript : Max India Limited, Q1 2027 Earnings Call, Aug 12, 2026

MaxiPARTS Sets Investor Webinar for FY26 Results

MarineMax (HZO): Buy, Sell, or Hold Post Q2 Earnings?

Tranche Update on MaxCyte, Inc.'s Equity Buyback Plan announced on May 12, 2026.

MaxCyte, Inc. has provided an update on its equity buyback plan announced on May 12, 2026. As of August 12, 2026, the company has repurchased 4,730,105 shares, representing 4.42% of its stock, for a total of $5.5 million. This repurchase completes the program initiated …

Enterprise value to revenue forward of Maximus, Inc. – NYSE:MMS

The article focuses on the enterprise value to revenue forward for Maximus, Inc. (NYSE: MMS) as presented on TradingView. It appears to be a financial data snippet, showing key information about the company's financials within the context of market data. The content is primarily …

(MXL) Volatility Zones as Tactical Triggers

This article provides an AI-driven analysis for Maxlinear Inc (NYSE: MXL), highlighting divergent sentiment and a mid-channel oscillation pattern. It presents three distinct trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—tailored for different risk profiles, along with multi-timeframe signal analysis and support/resistance levels. The …